Humana Inc.

JP Morgan has raised the price target on Humana (NYSE: HUM) from $66 to $84 and maintains its Neutral rating.

Jefferies has raised the price target on Humana (NYSE: HUM) from $82 to $90 and is maintaining its Buy rating on the stock, in light of a company makeover taking place. Says Jefferies, in its report, “Perhaps only the financials were the visible sign of a makeover, but the segment realignment also...

Wedbush has raised its price target from $71 to $79 on Humana Inc. (NYSE: HUM) and reiterates its Outperform rating. In the report, Wedbush writes, “Our Increased Estimates Are Based on Updated MA and PDP Enrollment Data That Exceeded our Expectations. We also continue to believe that utilization...

Wedbush Securities has raised the price target on Humana (NYSE: HUM) from $71 to $79 and maintains its Outperform rating.

Leerink Swann analysts Jason Gurda and Neil Bhalodkar maintained their Market Perform rating for shares of Humana Inc. (NYSE: HUM) with a 12-month valuation range of $56-$59. The analysts said that although Humana Inc. is likely to lose 5% of its PFFS members in 2011, it could also gain market...

Health insurer Humana Inc. (NYSE: HUM) announced plans to reduce its workforce by 1,400 employees. Humana Inc. said that although it plans to add 1,100 jobs in certain business areas, it will also cut 2,500 existing jobs from its payrolls. The move is being made as the health insurance company sees...